NAROPEINE 2 mg/ml, solution for injection in a bag 5 bags of 100 ml
Active ingredients: Ropivacaine hydrochloride, (S)-N-(2,6-dimethylphenyl)-1-ethylpiperidine-2-carboxamide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 bags of 100 mlinfiltration;péridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NAROPEINE 2 mg/ml, solution injectable en poche
- Pharmaceutical form
- solution injectable
- Route of administration
- infiltration;péridurale;périneurale
- Presentation description
- 5 poche(s) polypropylène de 100 ml, sous barquette stérile
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 May 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66370559CIP75599438CIP133400955994381Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE ROPIVACAÏNE MONOHYDRATÉsolution | 2,12 mg · 1 ml | SA |
| CHLORHYDRATE DE ROPIVACAÏNE ANHYDREsolution | 2 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.